Topotecan
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111659This classification denotes a camptothecin analogue, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7M7YKX2N15. European Medicines Agency schedules Topotecan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11191MIG. Topotecan generally arises in the molecular formula C23H23N3O5. The term TOPOTECAN is an International Non-Proprietary Name or INN. TOPOTECAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule topotecan under HS 29399900 and SITC 54149. As of Q4 2014, TOPOTECAN remains the US FDA Preferred Term for this commodity. Topotecan bears US NLM identifiers UMLS ID C0146224 and NCI Concept Code C1413. SMILES: O1CC2C(C(O)(CC)C1=O)CC1N(CC3C1NC1C(C3)C(CN(C)C)C(O)CC1)C2=O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.